Peptides for Hair Growth: An Honest Look at the Evidence

Peptide hair products make bold claims. But how much of this is science? We reviewed the evidence — and compared it to the treatments that actually work.

⚠ The Honest Answer

There is insufficient evidence to recommend any peptide as a primary treatment for hair loss. The established treatments — minoxidil and finasteride — have Grade A evidence from decades of large RCTs. No peptide comes close. If you are losing hair, see a dermatologist. The evidence-backed treatments work. Peptides are experimental.

Hair Loss Treatments Ranked by Evidence

These are ranked from strongest to weakest evidence. Notice where peptides fall.

TreatmentTypeEvidenceFDA ApprovedKey Detail
Minoxidil (Rogaine)Vasodilator, potassium channel openerA✓ YesFirst-line treatment. Start here.
Finasteride (Propecia)5-alpha reductase inhibitor (oral)A✓ YesFirst-line for male pattern hair loss. Add to minoxidil for additive benefit.
PRP (Platelet-Rich Plasma)Autologous growth factor injectionB✗ NoReasonable second-line option. Evidence is positive but less robust than minoxidil/finasteride.
GHK-Cu (Copper Peptide)Signal peptide — topicalC/D✗ NoInsufficient evidence. Cannot recommend as a primary treatment. Experimental use only if established treatments have failed and you understand the evidence limitations.
Thymosin Beta-4Actin-sequestering peptide — injectableD✗ NoNo human evidence. Significant legal and safety risks. Not recommended.

Detailed Treatment Breakdown

Minoxidil (Rogaine)

Evidence: Grade AStrong — decades of large RCTs

FDA-approved for androgenetic alopecia since 1988. 5% topical solution or foam applied twice daily. Demonstrated efficacy: ~40% of users see moderate to dense regrowth; ~80% experience slowing of hair loss. Mechanism: prolongs anagen phase, increases follicular size, improves microcirculation. Available OTC.

Verdict: First-line treatment. Start here.

Finasteride (Propecia)

Evidence: Grade AStrong — large RCTs

FDA-approved for male androgenetic alopecia. 1mg daily oral. Blocks DHT production — the primary hormonal driver of male pattern baldness. Demonstrated efficacy: 48% regrowth at 1 year, 66% at 2 years. Not approved for women (teratogenic risk). Requires prescription. Side effects (sexual) in ~2-4% of users.

Verdict: First-line for male pattern hair loss. Add to minoxidil for additive benefit.

PRP (Platelet-Rich Plasma)

Evidence: Grade BModerate — positive but variable data

Concentrated platelets from patient's own blood injected into scalp. Contains growth factors (PDGF, TGF-β, VEGF). Multiple RCTs show increased hair density and thickness. Typically 3-4 sessions at 4-6 week intervals, then maintenance. No FDA approval for hair loss (off-label). Variable protocols make comparison difficult. Cost: $500-1500/session.

Verdict: Reasonable second-line option. Evidence is positive but less robust than minoxidil/finasteride.

GHK-Cu (Copper Peptide)

Evidence: Grade C/DVery weak — no human hair RCTs

In vitro studies show GHK-Cu stimulates dermal papilla cell proliferation and growth factor production. However, no well-designed human clinical trials for hair growth exist. Most data is from wound healing studies where hair regrowth was a secondary observation. Topical application may not reach follicle depth at therapeutic concentrations. Cosmetic products rarely disclose peptide concentration.

Verdict: Insufficient evidence. Cannot recommend as a primary treatment. Experimental use only if established treatments have failed and you understand the evidence limitations.

Thymosin Beta-4

Evidence: Grade DAnimal data only — no human hair trials

Thymosin beta-4 promotes angiogenesis, cell migration, and stem cell recruitment. Animal studies (mice, rats) show accelerated hair follicle cycling and wound healing. Zero human clinical trials for hair growth. Injectable administration carries infection and contamination risks from unregulated sources. Not FDA-approved for any indication. Legal status: research chemical — cannot be legally prescribed.

Verdict: No human evidence. Significant legal and safety risks. Not recommended.

If You're Losing Hair: What Actually Works

1. See a dermatologist

Hair loss has multiple causes: androgenetic alopecia, telogen effluvium, alopecia areata, traction alopecia, nutritional deficiency. Each requires different treatment. A dermatologist can diagnose the cause and create an appropriate plan. Guessing wastes time and money.

2. Start with evidence-backed treatments

Minoxidil 5% topical (OTC) and finasteride 1mg oral (prescription) are the evidence-backed first-line treatments for androgenetic alopecia. They are affordable, studied for decades, and effective for most people. Add them together for synergistic benefit.

3. Address underlying causes

Iron deficiency, thyroid dysfunction, vitamin D deficiency, and rapid weight loss all cause reversible hair loss. Get blood work done. Fix the deficiency, and hair typically regrows without any peptide needed.

4. Consider PRP as a second-line option

PRP has Grade B evidence — positive but less robust than minoxidil/finasteride. It's expensive ($500-1500/session) and not covered by insurance. Consider it if first-line treatments are insufficient after 12 months.

5. Peptides are experimental — treat them as such

If you have tried the evidence-backed treatments for 12+ months without satisfactory results, and you fully understand that peptide evidence is Grade C/D, you may consider GHK-Cu as an experimental adjunct. Do not expect dramatic results. Do not replace minoxidil/finasteride with peptides. Do not inject unregulated substances.

Peptides for Hair Growth: FAQ